| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 5027 | 2018 |
| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 2016 | 2018 |
| Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ... The Journal of pathology 232 (2), 199-209, 2014 | 1591 | 2014 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10, 1-10, 2012 | 1013 | 2012 |
| Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections G Cattoretti, S Pileri, C Parravicini, MHG Becker, S Poggi, C Bifulco, G Key, ... The Journal of pathology 171 (2), 83-98, 1993 | 886 | 1993 |
| The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ... Journal for immunotherapy of cancer 7, 1-31, 2019 | 651 | 2019 |
| Impacts of European drought events: insights from an international database of text-based reports K Stahl, I Kohn, V Blauhut, J Urquijo, L De Stefano, V Acácio, S Dias, ... Natural Hazards and Earth System Sciences 16 (3), 801-819, 2016 | 317 | 2016 |
| The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ... Journal for immunotherapy of cancer 8 (1), e000155, 2020 | 234 | 2020 |
| A whole-slide foundation model for digital pathology from real-world data H Xu, N Usuyama, J Bagga, S Zhang, R Rao, T Naumann, C Wong, ... Nature 630 (8015), 181-188, 2024 | 205 | 2024 |
| Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon … B Mlecnik, C Bifulco, G Bindea, F Marliot, A Lugli, JJ Lee, I Zlobec, TT Rau, ... Journal of Clinical Oncology 38 (31), 3638, 2020 | 183 | 2020 |
| Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810 GS Falchook, R Leidner, E Stankevich, B Piening, C Bifulco, I Lowy, ... Journal for immunotherapy of cancer 4, 1-5, 2016 | 175 | 2016 |
| Multiparametric immune profiling in HPV–oral squamous cell cancer Z Feng, D Bethmann, M Kappler, C Ballesteros-Merino, A Eckert, RB Bell, ... JCI insight 2 (14), e93652, 2017 | 169 | 2017 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 163 | 2018 |
| Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015 J Galon, BA Fox, CB Bifulco, G Masucci, T Rau, G Botti, FM Marincola, ... Journal of translational medicine 14, 1-6, 2016 | 158 | 2016 |
| Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma Z Feng, S Puri, T Moudgil, W Wood, CC Hoyt, C Wang, WJ Urba, BD Curti, ... Journal for immunotherapy of cancer 3, 1-11, 2015 | 142 | 2015 |
| The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment PA Ascierto, M Capone, WJ Urba, CB Bifulco, G Botti, A Lugli, ... Journal of translational medicine 11, 1-4, 2013 | 142 | 2013 |
| Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells R Duhen, C Ballesteros-Merino, AK Frye, E Tran, V Rajamanickam, ... Nature communications 12 (1), 1047, 2021 | 137 | 2021 |
| Phase II trial of IL-12 plasmid transfection and PD-1 blockade in immunologically quiescent melanoma AP Algazi, CG Twitty, KK Tsai, M Le, R Pierce, E Browning, R Hermiz, ... Clinical Cancer Research 26 (12), 2827-2837, 2020 | 136 | 2020 |
| Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer AJ Gunderson, V Rajamanickam, C Bui, B Bernard, J Pucilowska, ... Oncoimmunology 10 (1), 1900635, 2021 | 129 | 2021 |
| Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence KL Meyer-Siegler, PL Vera, KA Iczkowski, C Bifulco, A Lee, PK Gregersen, ... Genes & Immunity 8 (8), 646-652, 2007 | 125 | 2007 |
